What is DermSource?
DermSource operates as a group purchasing organization, negotiating competitive pricing for independent pharmacies nationwide. Established in 2018 and notably expanded in 2023 through a partnership with Akron Generics, the organization focuses on generic pharmaceuticals, medical devices, and over-the-counter products. By leveraging a network of over 800 independently owned retail pharmacies, DermSource provides a dedicated purchasing platform designed to bolster the profitability and healthcare outcomes of its members. This strategic initiative aims to equip independent pharmacies with the tools to effectively counter rising prices and market marginalization.
How much funding has DermSource raised?
DermSource has raised a total of $20K across 1 funding round:
Debt
$20K
Debt (2021): $20K with participation from PPP
What's next for DermSource?
With the recent influx of substantial expansion capital, DermSource is poised for accelerated growth. The company's strategic focus will likely involve expanding its network of member pharmacies, further optimizing its purchasing platform, and potentially diversifying its product offerings beyond generic pharmaceuticals and medical supplies. The significant Series B/C stage funding suggests an intent to solidify its market leadership and potentially explore new avenues for revenue generation or strategic partnerships within the healthcare supply chain. This investment is critical for DermSource to enhance its competitive edge and continue its mission of supporting independent pharmacy viability.
See full DermSource company page
